Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 23,900
-250 (-1.04%)
Mar 13, 2026, 3:30 PM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 168.3 billion as of March 13, 2026. Its market cap has increased by 56.11% in one year.
Market Cap
168.30B
Enterprise Value
-54.16B
Revenue
66.51B
Ranking
n/a
PE Ratio
70.87
Stock Price
23,900.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 168.30B, an increase of 854.88%. That is a compound annual growth rate of 8.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 168.30B | 10.78% |
| Dec 30, 2025 | 151.92B | 40.65% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samil Pharmaceutical Co.,Ltd | 207.84B |
| JW Lifescience | 200.37B |
| AptaBio Therapeutics | 198.90B |
| REYON Pharmaceutical | 191.30B |
| Daihan Pharmaceutical | 172.58B |
| SAMSUNG PHARM. Co., LTD. | 169.42B |
| Dongwha Pharm.Co.,Ltd | 169.08B |
| Hana Pharm | 168.67B |